新股消息 | 海纳医药递表港交所

Group 1 - Nanjing Healthnice Pharmaceutical Technology Co., Ltd. has submitted an application for listing on the Hong Kong Stock Exchange, with CICC acting as the sole sponsor [1] - The company is an integrated pharmaceutical research and manufacturing entity that provides CXO services and has proprietary product pipelines, primarily commercialized through technology transfer [1] - According to a report by Frost & Sullivan, Healthnice ranks second among CXO service providers in China in terms of approved clinical trials and market approvals during the reporting period [1]